Nasdaq:US$14.54 (-0.06) | HKEX:HK$22.40 (-0.25) | AIM:£2.21 (-0.04)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2011

AACR 2011: Savolitinib (HMPL-504) against subcutaneous xenograft and orthotopic brain tumor models